Original Article
C-reactive Protein and Risk of Right Ventricular Dysfunction and Mortality in Patients With Acute Symptomatic Pulmonary Embolism
Marta Najarroa,◊, Carmen Rodríguezb,◊, Raquel Morillob,c, Luis Jara-Palomaresc,d, David R. Vinsone,f, Alfonso Murielg,h, Melchor Álvarez-Moni, Roger D. Yusenj, Behnood Bikdelik,l,m, David Jimenezb,c,i,
Corresponding author
a Emergency Department, Hospital Ramón y Cajal (IRYCIS), Madrid, Spain
b Respiratory Department, Hospital Ramón y Cajal (IRYCIS), Madrid, Spain
c CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain
d Respiratory Department, Hospital Virgen del Rocío, Sevilla, Spain
e The Permanente Medical Group and Kaiser Permanente Northern California Division of Research, Oakland, CA, USA
f Emergency Department, Kaiser Permanente Roseville Medical Center, Roseville, CA, USA
g Biostatistics Department, Hospital Ramón y Cajal, and Universidad de Alcalá (IRYCIS), Madrid, Spain
h CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
i Medicine Department, Universidad de Alcalá (IRYCIS), Madrid, Spain
j Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO, USA
k Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
l Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
m YNHH/Yale Center for Outcomes Research and Evaluation (CORE), New Haven, CT, USA
Ver más
